We observed that shikonin treatment further resulted in a 1.4-fold decreased H3T11-P signal in AD iNs at day 10 (Figures 7E and 7F) and led to a 50% reduction in neuronal protein levels of total PKM2 (Figure S7A). This evidence concerns the gene PKM and Alzheimer disease.